Nemes Rush Group LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Nemes Rush Group LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 10.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 15,694 shares of the healthcare conglomerate’s stock after acquiring an additional 1,438 shares during the quarter. Nemes Rush Group LLC’s holdings in UnitedHealth Group were worth $7,939,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in UnitedHealth Group during the fourth quarter worth $6,375,744,000. Raymond James Financial Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth about $1,914,740,000. Amundi raised its position in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Proficio Capital Partners LLC grew its position in shares of UnitedHealth Group by 76,830.4% in the fourth quarter. Proficio Capital Partners LLC now owns 1,888,641 shares of the healthcare conglomerate’s stock valued at $955,388,000 after purchasing an additional 1,886,186 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after purchasing an additional 861,854 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts recently commented on UNH shares. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Oppenheimer boosted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $524.48 on Tuesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $479.75 billion, a price-to-earnings ratio of 33.84, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The stock’s 50-day moving average is $509.10 and its 200-day moving average is $543.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.